Početna › Rak mjehura › Ohio › Columbus
Kliničke studije za Rak mjehura u gradu Columbus, OH
19 studija za Rak mjehura traži sudionike na lokacijama u gradu Columbus i okolici (unutar oko 30 milja). Otvorite studiju da biste vidjeli tko se može priključiti i kako kontaktirati tim studije.
Službeni tekst studije (engleski)
Tražite sudionike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
U tijeku regrutacijaFaza 3
- Ohio State University Comprehensive Cancer Center, Columbus
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
- Ohio State University Comprehensive Cancer Center, Columbus
- Mount Carmel East Hospital, Columbus
- The Mark H Zangmeister Center, Columbus
- i još 8
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
U tijeku regrutacijaFaza 2
- Riverside Methodist Hospital, Columbus
- Grant Medical Center, Columbus
- Doctors Hospital, Columbus
- i još 1
Futibatinib in Combination With Durvalumab Prior to Cystectomy for the Treatment of Muscle-Invasive Bladder Cancer Patients Who Are Ineligible for Cisplatin-based Therapy
U tijeku regrutacijaFaza 2
- Ohio State University Comprehensive Cancer Center, Columbus
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
U tijeku regrutacijaFaza 2
- Ohio State University Comprehensive Cancer Center, Columbus
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
U tijeku regrutacijaFaza 2
- Ohio State University Comprehensive Cancer Center, Columbus
- Mount Carmel East Hospital, Columbus
- Columbus Oncology and Hematology Associates Inc, Columbus
- i još 11
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
U tijeku regrutacijaFaza 3
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer -T, Columbus
Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease
U tijeku regrutacijaFaza 1
- Ohio State University, Columbus
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
U tijeku regrutacijaFaza 2
- Ohio State University, Columbus
- Central Ohio Urology Group (US Urology Partners), Gahanna · 7 mi udaljenosti
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
U tijeku regrutacijaFaza 1
- The Ohio State University (OSU), Columbus
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
U tijeku regrutacijaFaza 3
- Ohio State University Comprehensive Cancer Center, Columbus
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
U tijeku regrutacijaFaza 1/2
- The Ohio State University Comprehensive Cancer Center, Columbus
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
U tijeku regrutacijaFaza 1/2
- Central Ohio Urology Group, Gahanna · 7 mi udaljenosti
Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2
U tijeku regrutacijaOpažajna studija
- The Ohio State University, Columbus
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
U tijeku regrutacijaFaza 2/3
- The James Outpatient Care West Campus, Columbus
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
U tijeku regrutacijaFaza 2
- The Ohio State University Comprehensive Cancer Center (OSUCCC) - The James Cancer Hospital and Solove Research Institute, Columbus
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
U tijeku regrutacijaFaza 2
- Ohio State University Hospital, Columbus
- Ohio State University, Columbus
- OSU Wexner Medical Center & James Cancer Hospital, Columbus
- i još 2
Blue Light Cystoscopy With Cysview® Registry
U tijeku regrutacijaOpažajna studija
- Ohio State University Wexner Medical Center, Columbus
- Ohio State University, Columbus
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
U tijeku regrutacijaOpažajna studija
- Massive Bio SYNERGY-AI site, Columbus
Studije za Rak mjehura u drugim gradovima
- New York City, NY35 studija
- Nashville, TN31 studija
- Houston, TX31 studija
- Dallas, TX27 studija
- Boston, MA26 studija
- Washington, DC26 studija
- Los Angeles, CA24 studija
- Baltimore, MD24 studija
- St. Louis, MO22 studija
- Philadelphia, PA21 studija
- Seattle, WA21 studija
- Edison, NJ21 studija
Ostale studije u gradu Columbus
- Nemikrocelularni karcinom pluća56 studija
- Rak dojke39 studija
- Rak jajnika39 studija
- Rak (sve vrste)38 studija
- Rak pluća37 studija
- Akutna mijeloična leukemija35 studija
- Kronična limfocitna leukemija28 studija
- Metastatski karcinom27 studija
- Rak endometrija25 studija
- Kolorektalni rak24 studija
- Rak prostate24 studija
- Multipli mijelom24 studija
Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.